Emergent Biosolutions Inc. EBIT Margin

EBIT Margin of EBS for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBIT Margin growth rates and interactive chart. Earnings before interest and taxes margin is an indicator of a company's profitability. Calculated as earnings before interest and taxes (EBIT) divided by revenue. It is useful for comparison of companies with different debt levels and tax rates. And EBIT margin gives a clear picture about the underlying profitability of a company's core operations. EBIT is also referred to as operating earnings, operating profit, and profit before interest and taxes.

Highlights and Quick Summary

  • EBIT Margin for the quarter ending June 30, 2023 was -86.68% (a -3.37% decrease compared to previous quarter)
  • Year-over-year quarterly EBIT Margin increased by 395.31%
  • Annual EBIT Margin for 2022 was -15.41% (a -178.34% decrease from previous year)
  • Annual EBIT Margin for 2021 was 19.67% (a -29.47% decrease from previous year)
  • Annual EBIT Margin for 2020 was 27.89% (a 170.25% increase from previous year)
  • Twelve month EBIT Margin ending June 30, 2023 was -51.05% (a 52.66% increase compared to previous quarter)
  • Twelve month trailing EBIT Margin decreased by -554.99% year-over-year
Trailing EBIT Margin for the last four month:
30 Jun '23 31 Mar '23 31 Dec '22 30 Sep '22
-51.05% -33.44% -15.41% 11.22%
Visit stockrow.com/EBS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBIT Margin of Emergent Biosolutions Inc.

Most recent EBIT Marginof EBS including historical data for past 10 years.

Interactive Chart of EBIT Margin of Emergent Biosolutions Inc.

Emergent Biosolutions Inc. EBIT Margin for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 -86.68% -89.7% – – –
2022 -19.69% -17.5% -29.67% 2.08% -15.41%
2021 38.36% -10.55% 3.65% 27.81% 19.67%
2020 44.27% 15.91% 31.92% -6.03% 27.89%
2019 21.53% 22.67% -2.88% -14.27% 10.32%
2018 4.14% 12.27% 30.34% -8.06% 11.48%
2017 27.39% 31.97% 8.46% 12.76% 22.16%
2016 33.56% 24.82% -2.24% 20.55% 21.58%
2015 60.35% 39.88% 17.01% -44.49% 28.92%
2014 74.05% 22.49% 7.13% -47.25% 22.05%
2013 23.74% 20.37% 17.85% -30.97% 13.69%
2012 25.41% 14.74% – – 10.63%

Business Profile of Emergent Biosolutions Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic
© stockrow.com